The company will compete for up to 320 million dollars In clinical research and operations support services
Fairfax, Virginia.And the August 15, 2022 /PRNewswire/ — The Division of Cancer Epidemiology and Genetics (DCEG) of the National Institutes of Health (NIH) has selected the ICF Global Counseling and Digital Services Division (NASDAQ):ICFI) as one of five winners of a new multi-award contract for Indefinite Delivery, Indefinite Quantity (IDIQ) to provide clinical and epidemiological process support for studies and other research activities.
The value of the IDIQ awarded in the second quarter of 2022 is 320 million dollars All winners have a 10-year term, including a five-year base and five-year option period.
The ICF’s health research team and public health experts will support the DCEG programs, and approximately 150 epidemiologists, geneticists and biostatisticians, in three main areas: field preparation and study management, exposure assessment and clinical support. This will include the management of concurrent and interdisciplinary local and international epidemiological and genetic studies of varying volumes and complexity.
“ICF has a long history of supporting the epidemiological and clinical research programs of the National Institutes of Health with technical expertise in scientific research and survey operations, statistical data management, digital updating of data collection systems and more,” he said. Mark LeeExecutive Vice President and Public Sector Leader. “We are excited to bring all of these skills to support DCEG in achieving its mission – to discover the causes of cancer and inform prevention in the future.”
For more than 40 years, ICF has supported US Department of Health and Human Services clients in all departments with comprehensive services in public health, epidemiology, survey research, genetics, biostatistics, clinical informatics, digital updating, and more.
ICF combines deep field and scientific expertise with leading-edge technology solutions to help public health clients meet their greatest challenges and design solutions that increase understanding of the causes of disease and improve outcomes for the entire population. ICF is also a leading provider of low-code, open-source and cloud-native solutions, which enables the company to provide customers with flexible applications and tools in a cost-effective environment.
ICF is a global consulting services company with nearly 8,000 full- and part-time employees, but we are not typical consultants. At the ICF, business analysts and policy specialists work alongside digital strategists, data scientists, and innovators. We combine unparalleled industry expertise with cutting-edge engagement capabilities to help organizations solve their most complex challenges. Since 1969, public and private clients have worked with ICF to weather change and shape the future. Learn more through icf.com.
Caution regarding forward-looking statements
Statements that are not historical facts and involve known and unknown risks and uncertainties are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. Such statements may relate to and involve our current expectations about our results, plans, operations, and prospects, including: Those relating to the government contracting industry in general; our own business, including our reliance on contracts with US federal government agencies; Our ability to successfully acquire and integrate business; and the effects of the novel coronavirus disease (COVID-19) and relevant federal, state, and local actions and reactions on the health of our employees and the health of our customers, the continuity of our operations and our customers, the results of our operations and our outlook. These and other factors could cause our actual results to differ from those indicated in the forward-looking statements contained in the “Risk Factors” section of our securities filings with the Securities and Exchange Commission. The forward-looking statements included here are made only as of the date hereof, and we specifically disclaim any obligation to update such statements in the future.
Contact: Lauren DykeAnd the [email protected]+1.571.373.5577